NASDAQ:ABSI
Absci Corporation Stock Company Profile
$5.08
+0.1000 (+2.01%)
At Close: May 03, 2024
Information
18105 SE Mill Plain Boulevard
Vancouver WA 98683
360 949 1041
www.absci.com
Industry: Biotechnology
Sector: Healthcare
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
